Dr. Goshua is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
330 Cedar St
New Haven, CT 06510- Is this information wrong?
Education & Training
- Yale-New Haven Medical CenterFellowship, Hematology and Medical Oncology, 2019 - 2022
- Yale-New Haven Medical CenterChief Residency, Internal Medicine, 2018 - 2019
- Yale-New Haven Medical CenterResidency, Internal Medicine, 2015 - 2018
- University of Kentucky College of MedicineClass of 2015
Certifications & Licensure
- CT State Medical License 2018 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- Inductee
- Junior AOA Alpha Omega Alpha, 2014
- GHHS Arnold P Gold Foundation, 2014
Publications & Presentations
PubMed
- Cost-effectiveness of adding quizartinib to induction chemotherapy for patients withmutant acute myeloid leukemia.Kishan K Patel, Jan Philipp Bewersdorf, Rory M Shallis, Nikolai A Podoltsev, Tariq Kewan, Jessica Stempel, Lourdes Mendez, Maximilian Stahl, Eytan M Stein, Scott F Hun...> ;Leukemia & Lymphoma. 2024 Apr 22
- Cost-effectiveness of prophylaxis with recombinant versus plasma-derived VWF in severe von Willebrand disease in the US.Christina Waldron, Satoko Ito, Daniel Wang, Cecily Allen, Giri Viswanathan, Robert D Bona, Adam Cuker, George Goshua> ;Blood. 2024 Apr 18
- Decreasing alloimmunization-specific mortality in sickle cell disease in the United States: Cost-effectiveness of a shared transfusion resource.Satoko Ito, Ankur Pandya, Ronald G Hauser, Lakshmanan Krishnamurti, Edward Stites, Chris Tormey, Harlan M Krumholz, Jeanne E Hendrickson, George Goshua> ;American Journal of Hematology. 2024 Apr 1
- Join now to see all
Press Mentions
- Sickle Cell Cure Will Be Cost-Effective if Health Disparities Considered -Study FindsDecember 13th, 2022
- High Price for Gene Therapy ― but Cost-Effective in Sickle CellDecember 12th, 2022
- ASH 2022: Sickle Cell Disease in the Big EasyDecember 5th, 2022
- Join now to see all
Hospital Affiliations
- Yale-New Haven HospitalNew Haven, Connecticut
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: